These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 14769016)
1. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016 [TBL] [Abstract][Full Text] [Related]
2. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Saphire EO; Parren PW; Pantophlet R; Zwick MB; Morris GM; Rudd PM; Dwek RA; Stanfield RL; Burton DR; Wilson IA Science; 2001 Aug; 293(5532):1155-9. PubMed ID: 11498595 [TBL] [Abstract][Full Text] [Related]
4. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472 [TBL] [Abstract][Full Text] [Related]
5. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775 [TBL] [Abstract][Full Text] [Related]
6. The antigenic structure of the HIV gp120 envelope glycoprotein. Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684 [TBL] [Abstract][Full Text] [Related]
7. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12. Pantophlet R; Wilson IA; Burton DR Protein Eng Des Sel; 2004 Oct; 17(10):749-58. PubMed ID: 15542540 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6. Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506 [TBL] [Abstract][Full Text] [Related]
9. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973 [TBL] [Abstract][Full Text] [Related]
10. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. Stanfield RL; Gorny MK; Williams C; Zolla-Pazner S; Wilson IA Structure; 2004 Feb; 12(2):193-204. PubMed ID: 14962380 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades. Zhang MY; Shu Y; Sidorov I; Dimitrov DS Antiviral Res; 2004 Mar; 61(3):161-4. PubMed ID: 15168796 [TBL] [Abstract][Full Text] [Related]
12. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120. Stura EA; Stanfield RL; Fieser GG; Silver S; Roguska M; Hincapie LM; Simmerman HK; Profy AT; Wilson IA Proteins; 1992 Dec; 14(4):499-508. PubMed ID: 1438187 [TBL] [Abstract][Full Text] [Related]
13. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site. Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968 [TBL] [Abstract][Full Text] [Related]
14. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography. Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463 [TBL] [Abstract][Full Text] [Related]
15. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site. Julien JP; Bryson S; Nieva JL; Pai EF J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005 [TBL] [Abstract][Full Text] [Related]
16. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420 [TBL] [Abstract][Full Text] [Related]
17. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight. Covaceuszach S; Cattaneo A; Lamba D Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for the interaction between focal adhesion kinase and CD4. Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954 [TBL] [Abstract][Full Text] [Related]
20. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization. Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]